{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:11:04Z","timestamp":1789798264326,"version":"4.0.1"},"reference-count":209,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Global pandemics are most likely initiated via zoonotic transmission to humans in which respiratory viruses infect airways with relevance to mucosal systems. Out of the known pandemics, five were initiated by respiratory viruses including current ongoing coronavirus disease 2019 (COVID-19). Striking progress in vaccine development and therapeutics has helped ameliorate the mortality and morbidity by infectious agents. Yet, organism replication and virus spread through mucosal tissues cannot be directly controlled by parenteral vaccines. A novel mitigation strategy is needed to elicit robust mucosal protection and broadly neutralizing activities to hamper virus entry mechanisms and inhibit transmission. This review focuses on the oral mucosa, which is a critical site of viral transmission and promising target to elicit sterile immunity. In addition to reviewing historic pandemics initiated by the zoonotic respiratory RNA viruses and the oral mucosal tissues, we discuss unique features of the oral immune responses. We address barriers and new prospects related to developing novel therapeutics to elicit protective immunity at the mucosal level to ultimately control transmission.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1220610","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T05:00:34Z","timestamp":1697691634000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Oral mucosa immunity: ultimate strategy to stop spreading of pandemic viruses"],"prefix":"10.3389","volume":"14","author":[{"given":"Hyesun","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.11.088815","article-title":"The classical definition of a pandemic is not elusive","volume":"89","author":"Kelly","year":"2011","journal-title":"Bull World Health Organ"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.021","article-title":"Emerging pandemic diseases: how we got to COVID-19","volume":"182","author":"Morens","year":"2020","journal-title":"Cell"},{"key":"B3","volume-title":"Pandemics: Risks, Impacts, and Mitigation","author":"Madhav","year":"2017"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61684-5","article-title":"Prediction and prevention of the next pandemic zoonosis","volume":"380","author":"Morse","year":"2012","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/23998083211072588","article-title":"The COVID years: Predictable unpredictability","volume":"49","author":"Batty","year":"2022","journal-title":"Environ Plann B: Urban Analytics City Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1086\/652860","article-title":"The origin and prevention of pandemics","volume":"50","author":"Pike","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42269-022-00701-7","article-title":"Cross-species virus transmission and its pandemic potential","volume":"46","author":"Choudhury","year":"2022","journal-title":"Bull Natl Salmon Resour Cent"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.631736","article-title":"Pandemics throughout history","volume":"11","author":"Piret","year":"2020","journal-title":"Front Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3201\/eid1201.051254","article-title":"Influenza pandemics of the 20th century","volume":"12","author":"Kilbourne","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2001.0900","article-title":"Emerging infectious pathogens of wildlife","volume":"356","author":"Dobson","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00004-08","article-title":"Cross-species virus transmission and the emergence of new epidemic diseases","volume":"72","author":"Parrish","year":"2008","journal-title":"Microbiol Mol Biol Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.717941","article-title":"Cross-species transmission of coronaviruses in humans and domestic mammals, what are the ecological mechanisms driving transmission, spillover, and disease emergence","volume":"9","author":"Nova","year":"2021","journal-title":"Front Public Health"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp048039","article-title":"Crossing the species barrier\u2013one small step to man, one giant leap to mankind","volume":"350","author":"Klempner","year":"2004","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nm1151","article-title":"Molecular constraints to interspecies transmission of viral pathogens","volume":"10","author":"Webby","year":"2004","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature05775","article-title":"Origins of major human infectious diseases","volume":"447","author":"Wolfe","year":"2007","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.5822\/978-1-61091-611-0_8","article-title":"Emerging diseases from animals","volume-title":"State of the World 2015: Confronting Hidden Threats to Sustainability","author":"Machalaba","year":"2015"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/v15040980","article-title":"Zoonotic animal influenza virus and potential mixing vessel hosts","volume":"15","author":"Abdelwhab","year":"2023","journal-title":"Viruses"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-gmb-2020-0355","article-title":"Zoonotic spillover: Understanding basic aspects for better prevention","volume":"44","author":"Ellwanger","year":"2021","journal-title":"Genet Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03146-14","article-title":"Influenza virus reservoirs and intermediate hosts: dogs, horses, and new possibilities for influenza virus exposure of humans","volume":"89","author":"Parrish","year":"2015","journal-title":"J Virol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0903812","article-title":"Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009","volume":"360","author":"Shinde","year":"2009","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans","volume":"325","author":"Garten","year":"2009","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.OH-0001-2012","article-title":"RNA viruses: A case study of the biology of emerging infectious diseases","volume":"1","author":"Woolhouse ME","year":"2013","journal-title":"Microbiol Spectr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38050","article-title":"RNA virus genomics: a world of possibilities","volume":"119","author":"Holmes","year":"2009","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2008.070063","article-title":"Emerging pathogens: challenges and successes of molecular diagnostics","volume":"10","author":"Dong","year":"2008","journal-title":"J Mol Diagn"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ilar\/ilx026","article-title":"Are RNA viruses candidate agents for the next global pandemic? A review","volume":"58","author":"Carrasco-Hernandez","year":"2017","journal-title":"ILAR J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature06536","article-title":"Global trends in emerging infectious diseases","volume":"451","author":"Jones","year":"2008","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/v13040537","article-title":"Key factors that enable the pandemic potential of RNA viruses and inter-species transmission: A systematic review","volume":"13","author":"Alvarez-Munoz","year":"2021","journal-title":"Viruses"},{"key":"B28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-022-00517-8","article-title":"Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines","volume":"15","author":"Mouro","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41590-022-01405-w","article-title":"SARS-CoV-2 mucosal vaccine","volume":"24","author":"Houston","year":"2023","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.957107","article-title":"Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission","volume":"13","author":"Russell","year":"2022","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/v12080862","article-title":"Emerging role of mucosal vaccine in preventing infection with avian influenza A viruses","volume":"12","author":"Wang","year":"2020","journal-title":"Viruses"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/v4091438","article-title":"Evasion of influenza A viruses from innate and adaptive immune responses","volume":"4","author":"van de Sandt","year":"2012","journal-title":"Viruses"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ni1343","article-title":"Influenza and the challenge for immunology","volume":"7","author":"Doherty","year":"2006","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002198","article-title":"Imperfect vaccination can enhance the transmission of highly virulent pathogens","volume":"13","author":"Read","year":"2015","journal-title":"PloS Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.801522","article-title":"A detailed overview of immune escape, antibody escape, partial vaccine escape of SARS-CoV-2 and their emerging variants with escape mutations","volume":"13","author":"Chakraborty","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00535-6","article-title":"Transmissibility and transmission of respiratory viruses","volume":"19","author":"Leung","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-1263PP","article-title":"Coughs and sneezes: their role in transmission of respiratory viral infections, including SARS-CoV-2","volume":"202","author":"Dhand","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd9149","article-title":"Airborne transmission of respiratory viruses","volume":"373","author":"Wang","year":"2021","journal-title":"Science"},{"key":"B41","article-title":"The great mask debate: A debate that shouldn\u2019t be a debate at all","volume":"119","author":"Raymond","year":"2020","journal-title":"WMJ"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.786042","article-title":"Saliva quantification of SARS-CoV-2 in real-time PCR from asymptomatic or mild COVID-19 adults","volume":"12","author":"Carrouel","year":"2021","journal-title":"Front Microbiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2006874117","article-title":"The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission","volume":"117","author":"Stadnytskyi","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B44","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41591-021-01296-8","article-title":"SARS-CoV-2 infection of the oral cavity and saliva","volume":"27","author":"Huang","year":"2021","journal-title":"Nat Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1465-9921-8-73","article-title":"Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses","volume":"8","author":"Nicholls","year":"2007","journal-title":"Respir Res"},{"key":"B46","article-title":"The new pandemic influenza A\/(H1N1)pdm09 virus: is it really \u201cnew\u201d","volume":"57","author":"Baldo","year":"2016","journal-title":"J Prev Med Hyg"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2186608","DOI":"10.1080\/22221751.2023.2186608","article-title":"Characterization of neurotropic HPAI H5N1 viruses with novel genome constellations and mammalian adaptive mutations in free-living mesocarnivores in Canada","volume":"12","author":"Alkie","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00336-21","article-title":"Use of saliva swab for detection of influenza virus in patients admitted to an emergency department","volume":"9","author":"Galar","year":"2021","journal-title":"Microbiol Spectr"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263419","article-title":"Saliva as a useful tool for evaluating upper mucosal antibody response to influenza","volume":"17","author":"Tsunetsugu-Yokota","year":"2022","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.667956","article-title":"Stability and infectivity of SARS-CoV-2 and viral RNA in water, commercial beverages, and bodily fluids","volume":"12","author":"Fukuta","year":"2021","journal-title":"Front Microbiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-66-12-2743","article-title":"Survival characteristics of airborne human coronavirus 229E","volume":"66","author":"Ijaz","year":"1985","journal-title":"J Gen Virol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es2013.18.38.20590","article-title":"Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions","volume":"18","author":"van Doremalen","year":"2013","journal-title":"Euro Surveill"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaerosci.2017.09.009","article-title":"Survival of aerosolized coronavirus in the ambient air","volume":"115","author":"Pyankov","year":"2018","journal-title":"J Aerosol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.13.20063784","article-title":"Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions","volume":"1","author":"Fears","year":"2020","journal-title":"medRxiv"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1","author":"van Doremalen","year":"2020","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13567-014-0073-z","article-title":"Evidence of infectivity of airborne porcine epidemic diarrhea virus and detection of airborne viral RNA at long distances from infected herds","volume":"45","author":"Alonso","year":"2014","journal-title":"Vet Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy221","article-title":"Influenza virus infectivity is retained in aerosols and droplets independent of relative humidity","volume":"218","author":"Kormuth","year":"2018","journal-title":"J Infect Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1086\/597073","article-title":"Transmission of influenza virus via aerosols and fomites in the Guinea pig model","volume":"199","author":"Mubareka","year":"2009","journal-title":"J Infect Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02130","article-title":"Viral emerging diseases: challenges in developing vaccination strategies","volume":"11","author":"Trovato","year":"2020","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202203_28248","article-title":"Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis","volume":"26","author":"Huang","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab931","article-title":"Vaccine effectiveness against life-threatening influenza illness in US children","volume":"75","author":"Olson","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13526","article-title":"Vaccines, adjuvants and key factors for mucosal immune response","volume":"167","author":"Correa","year":"2022","journal-title":"Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.116576","article-title":"Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys","volume":"108","author":"Hart","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0022-1759(94)00275-2","article-title":"IgA, IgG and IgM quantification in bronchoalveolar lavage fluids from allergic rhinitics, allergic asthmatics, and normal subjects by monoclonal antibody-based immunoenzymetric assays","volume":"179","author":"Peebles","year":"1995","journal-title":"J Immunol Methods"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.02.024","article-title":"Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract","volume":"368","author":"Wu","year":"2007","journal-title":"J Mol Biol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"ofac135","DOI":"10.1093\/ofid\/ofac135","article-title":"Viral load among vaccinated and unvaccinated, asymptomatic and symptomatic persons infected with the SARS-CoV-2 delta variant","volume":"9","author":"Acharya","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2009758","article-title":"Asymptomatic transmission, the Achilles\u2019 Heel of current strategies to control Covid-19","volume":"382","author":"Gandhi","year":"2020","journal-title":"N Engl J Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/v14020187","article-title":"Mucosal vaccines, sterilizing immunity, and the future of SARS-CoV-2 virulence","volume":"14","author":"Focosi","year":"2022","journal-title":"Viruses"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6030058","article-title":"The future of influenza vaccines: A historical and clinical perspective","volume":"6","author":"Bouvier","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.10.017","article-title":"Sterilizing immunity: understanding COVID-19","volume":"55","author":"Wahl","year":"2022","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052424","article-title":"Mucosal ecological network of epithelium and immune cells for gut homeostasis and tissue healing","volume":"35","author":"Kurashima","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01787","article-title":"Mucosal mesenchymal cells: secondary barrier and peripheral educator for the gut immune system","volume":"8","author":"Kurashima","year":"2017","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/B978-0-7020-6896-6.00020-X","article-title":"20 - host defenses at mucosal surfaces","volume-title":"Clinical Immunology","author":"Boyaka","year":"2019"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxab056","article-title":"Mucosal vaccines: wisdom from now and then","volume":"33","author":"Kiyono","year":"2021","journal-title":"Int Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.705206","article-title":"Oral versus gastrointestinal mucosal immune niches in homeostasis and allostasis","volume":"12","author":"Su\u00e1rez","year":"2021","journal-title":"Front Immunol"},{"key":"B76","article-title":"The mucosal immune system","author":"Janeway","year":"2001","journal-title":"Garland Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.08.005","article-title":"Tissue-specific immunity at the oral mucosal barrier","volume":"39","author":"Moutsopoulos","year":"2018","journal-title":"Trends Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms13044295","article-title":"Salivary defense proteins: their network and role in innate and acquired oral immunity","volume":"13","author":"F\u00e1bi\u00e1n","year":"2012","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/ijos.2014.48","article-title":"The mucosal immune system in the oral cavity-an orchestra of T cell diversity","volume":"6","author":"Wu","year":"2014","journal-title":"Int J Oral Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.2012.01490.x","article-title":"Role of the junctional epithelium in periodontal innate defense and homeostasis","volume":"47","author":"Tsukamoto","year":"2012","journal-title":"J Periodontal Res"},{"key":"B81","volume-title":"Histology, Oral Mucosa","author":"Brizuela","year":"2022"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051643","article-title":"Oral microbes and mucosal dendritic cells, \u201cSpark and flame\u201d of local and distant inflammatory diseases","volume":"21","author":"Meghil","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212149","article-title":"Immune tolerance in the oral mucosa","volume":"22","author":"Pelaez-Prestel","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601629","article-title":"The importance of dendritic cells in maintaining immune tolerance","volume":"198","author":"Audiger","year":"2017","journal-title":"J Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2695","article-title":"IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39","volume":"14","author":"Mascanfroni","year":"2013","journal-title":"Nat Immunol"},{"key":"B86","doi-asserted-by":"crossref","first-page":"228 p","DOI":"10.3389\/978-2-88974-181-6","volume-title":"Molecular Mechanisms of Dendritic Cell-Mediated Immune Tolerance and Autoimmunity","author":"Zhou","year":"2022"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1309.031","article-title":"IL-10-producing T regulatory type 1 cells and oral tolerance","volume":"1029","author":"Battaglia","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1124\/pr.113.007823","article-title":"Aryl hydrocarbon receptor control of adaptive immunity","volume":"65","author":"Quintana","year":"2013","journal-title":"Pharmacol Rev"},{"key":"B89","article-title":"Significance of different J chain profiles in human tissues: generation of IgA and IgM with binding site for secretory component is related to the J chain expressing capacity of the total local immunocyte population, including IgG and IgD producing cells, and depends on the clinical state of the tissue","volume":"58","author":"Brandtzaeg","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00819.x","article-title":"Humoral immune responses in periodontal disease may have mucosal and systemic immune features","volume":"115","author":"Kinane","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4049\/jimmunol.1601775","article-title":"Inducing mucosal igA: A challenge for vaccine adjuvants and delivery systems","volume":"199","author":"Boyaka","year":"2017","journal-title":"J Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/nri2322","article-title":"The regulation of IgA class switching","volume":"8","author":"Cerutti","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0346","article-title":"Human blood IgM \u201cmemory\u201d B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire","volume":"104","author":"Weller","year":"2004","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.3.1166","article-title":"CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans","volume":"98","author":"Weller","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2003.01775.x","article-title":"T lymphocyte dependence of the antibody response to \u201cT lymphocyte independent type 2\u201d antigens","volume":"111","author":"Jeurissen","year":"2004","journal-title":"Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-030409-101314","article-title":"Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis","volume":"28","author":"Fagarasan","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2006.10.001","article-title":"Intestinal IgA synthesis: a primitive form of adaptive immunity that regulates microbial communities in the gut","volume":"19","author":"Suzuki","year":"2007","journal-title":"Semin Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2032057","DOI":"10.1155\/2020\/2032057","article-title":"The effects of secretory igA in the mucosal immune system","volume":"2020","author":"Li","year":"2020","journal-title":"BioMed Res Int"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106754118","article-title":"B cell residency but not T cell-independent IgA switching in the gut requires innate lymphoid cells","volume":"118","author":"Zheng","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B100","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41541-021-00341-4","article-title":"Is the oral microbiome a source to enhance mucosal immunity against infectious diseases","volume":"6","author":"Zenobia","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2019.06.001","article-title":"Regulation of oral immune tolerance by the microbiome in food allergy","volume":"60","author":"Stephen-Victor","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8680-5","article-title":"Mechanisms of oral tolerance","volume":"55","author":"Tordesillas","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.687513","article-title":"Oral microbiome dysbiosis is associated with symptoms severity and local immune\/inflammatory response in COVID-19 patients: A cross-sectional study","volume":"12","author":"Soffritti","year":"2021","journal-title":"Front Microbiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12866-020-01801-y","article-title":"Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture","volume":"20","author":"Caselli","year":"2020","journal-title":"BMC Microbiol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2016.54","article-title":"Human intestinal barrier function in health and disease","volume":"7","author":"K\u00f6nig","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"127055","DOI":"10.1016\/j.micres.2022.127055","article-title":"Oral dysbiosis and its linkage with SARS-CoV-2 infection","volume":"261","author":"Gupta","year":"2022","journal-title":"Microbiol Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/dj9040043","article-title":"The impact of oral health on respiratory viral infection","volume":"9","author":"Tada","year":"2021","journal-title":"Dent J"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00037-15","article-title":"Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals","volume":"6","author":"Bassis","year":"2015","journal-title":"MBio"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253293","article-title":"The human microbiome and COVID-19: A systematic review","volume":"16","author":"Yamamoto","year":"2021","journal-title":"PloS One"},{"key":"B110","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41522-021-00262-z","article-title":"Author Correction: Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization","volume":"7","author":"Wu","year":"2021","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B111","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.fshw.2018.12.001","article-title":"Oral microbiota: A new view of body health","volume":"8","author":"Lu","year":"2019","journal-title":"Food Sci Hum Wellness"},{"key":"B112","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/gb-2012-13-6-r42","article-title":"Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples","volume":"13","author":"Segata","year":"2012","journal-title":"Genome Biol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1522149113","article-title":"Biogeography of a human oral microbiome at the micron scale","volume":"113","author":"Mark Welch","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.4103\/jomfp.JOMFP_304_18","article-title":"Oral microbiome: Unveiling the fundamentals","volume":"23","author":"Deo","year":"2019","journal-title":"J Oral Maxillofac Pathol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl5450","article-title":"Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier","volume":"374","author":"Silva","year":"2021","journal-title":"Science"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22157821","article-title":"An overview of physical, microbiological and immune barriers of oral mucosa","volume":"22","author":"\u015eenel","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i29.9653","article-title":"Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells","volume":"20","author":"Mann","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/scipharm87040027","article-title":"Recent approaches for solid dose vaccine delivery","volume":"87","author":"Jahan","year":"2019","journal-title":"Sci Pharm"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2015.07.013","article-title":"Mechanisms of oral tolerance","volume":"62","author":"Commins","year":"2015","journal-title":"Pediatr Clin North Am"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9010001","article-title":"Advances in oral subunit vaccine design","volume":"9","author":"Van der Weken","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1177\/0022034520926126","article-title":"Inflammatory networks linking oral microbiome with systemic health and disease","volume":"99","author":"Kleinstein","year":"2020","journal-title":"J Dent Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.08.009","article-title":"Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses","volume":"29","author":"Hall","year":"2008","journal-title":"Immunity"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062026","article-title":"Impact of oral typhoid vaccination on the human gut microbiota and correlations with s. Typhi-specific immunological responses","volume":"8","author":"Eloe-Fadrosh","year":"2013","journal-title":"PloS One"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00726","article-title":"Gut dysbiosis thwarts the efficacy of vaccine against mycobacterium tuberculosis","volume":"11","author":"Nadeem","year":"2020","journal-title":"Front Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.752304","article-title":"Microbial-driven immunological memory and its potential role in microbiome editing for the prevention of colorectal cancer","volume":"11","author":"Campillo-Gimenez","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5MR0617-216R","article-title":"The potential of the microbiota to influence vaccine responses","volume":"103","author":"Lynn","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2020.12.014","article-title":"Probiotics: A potential immunomodulator in COVID-19 infection management","volume":"87","author":"Singh","year":"2021","journal-title":"Nutr Res"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.07.002","article-title":"Mucosal vaccine delivery: A focus on the breakthrough of specific barriers","volume":"12","author":"Huang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.37477","article-title":"Design and characterization of lipid nanocarriers for oral delivery of immunotherapeutic peptides","volume":"111","author":"Calder\u00f3n-Col\u00f3n","year":"2022","journal-title":"J BioMed Mater Res A"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-021-00537-9","article-title":"Recent advances in nano\/microparticle-based oral vaccines","volume":"51","author":"Li","year":"2021","journal-title":"J Pharm Investig"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2025759118","article-title":"A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge","volume":"118","author":"Sia","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S178809","article-title":"Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs","volume":"13","author":"Dhakal","year":"2018","journal-title":"Int J Nanomed"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01207","article-title":"A novel synthetic dual agonistic liposomal TLR4\/7 adjuvant promotes broad immune responses in an influenza vaccine with minimal reactogenicity","volume":"11","author":"Sato-Kaneko","year":"2020","journal-title":"Front Immunol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"100104","DOI":"10.1016\/j.medidd.2021.100104","article-title":"Liposomes and mRNA: Two technologies together create a COVID-19 vaccine","volume":"12","author":"Gregoriadis","year":"2021","journal-title":"Med Drug Discov"},{"key":"B136","doi-asserted-by":"publisher","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int J Pharm"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3390\/polym14194195","article-title":"Design strategies for and stability of mRNA-lipid nanoparticle COVID-19 vaccines","volume":"14","author":"Liu","year":"2022","journal-title":"Polymers"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.7150\/thno.70853","article-title":"Advances in the polymeric delivery of nucleic acid vaccines","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/polym15071615","article-title":"The role of mucoadhesion and mucopenetration in the immune response induced by polymer-based mucosal adjuvants","volume":"15","author":"Vasquez-Mart\u00ednez","year":"2023","journal-title":"Polymers"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00934","article-title":"Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs","volume":"9","author":"Dhakal","year":"2018","journal-title":"Front Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2017.01.020","article-title":"Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate\/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes","volume":"201","author":"Chowdhury","year":"2017","journal-title":"Vet Microbiol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.07.037","article-title":"Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice","volume":"27","author":"Okamoto","year":"2009","journal-title":"Vaccine"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(00)00330-8","article-title":"A novel bioadhesive intranasal delivery system for inactivated influenza vaccines","volume":"70","author":"Singh","year":"2001","journal-title":"J Control Release"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00326","article-title":"Mucosal and systemic immune responses to influenza H7N9 antigen HA1-2 co-delivered intranasally with flagellin or polyethyleneimine in mice and chickens","volume":"8","author":"Song","year":"2017","journal-title":"Front Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11051-022-05396-5","article-title":"Polymeric nanoparticles as therapeutic agents against coronavirus disease","volume":"24","author":"Charelli","year":"2022","journal-title":"J Nanopart Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.05.060","article-title":"Buccal and sublingual vaccine delivery","volume":"190","author":"Kraan","year":"2014","journal-title":"J Control Release"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2010.12.014","article-title":"Sublingual mucosa: A new vaccination route for systemic and mucosal immunity","volume":"54","author":"Kweon","year":"2011","journal-title":"Cytokine"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.03.017","article-title":"Sublingual vaccination and delivery systems","volume":"332","author":"Paris","year":"2021","journal-title":"J Control Release"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027953","article-title":"Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza","volume":"6","author":"Shim","year":"2011","journal-title":"PloS One"},{"key":"B150","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s12275-014-4289-4","article-title":"Preliminary study about sublingual administration of bacteria-expressed pandemic H1N1 influenza vaccine in miniature pigs","volume":"52","author":"Kim","year":"2014","journal-title":"J Microbiol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300889","article-title":"Sublingual dissolving microneedle (SLDMN)-based vaccine for inducing mucosal immunity against SARS-CoV-2","author":"Kim","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29269","article-title":"Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites","volume":"10","author":"Nizard","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"B153","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jconrel.2016.02.014","article-title":"Mucosal vaccine delivery: Current state and a pediatric perspective","volume":"240","author":"Shakya","year":"2016","journal-title":"J Control Release"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.7774\/cevr.2022.11.3.235","article-title":"Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants","volume":"11","author":"Anggraeni","year":"2022","journal-title":"Clin Exp Vaccine Res"},{"key":"B155","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/infdis\/jiab561","article-title":"Oral vaccination protects against severe acute respiratory syndrome coronavirus 2 in a Syrian hamster challenge model","volume":"225","author":"Johnson","year":"2022","journal-title":"J Infect Dis"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233520","article-title":"Influenza vaccine efficacy induced by orally administered recombinant baculoviruses","volume":"15","author":"Basak","year":"2020","journal-title":"PloS One"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.04.013","article-title":"Mucosal immune responses to infection and vaccination in the respiratory tract","volume":"55","author":"Mettelman","year":"2022","journal-title":"Immunity"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11080375","article-title":"Mucosal vaccination via the respiratory tract","volume":"11","author":"Hellfritzsch","year":"2019","journal-title":"Pharmaceutics"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: Historical successes and current challenges","author":"Minor","year":"2015","journal-title":"Virol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piz083","article-title":"Understanding immunity in children vaccinated with live attenuated influenza vaccine","volume":"9","author":"Shannon","year":"2020","journal-title":"J Pediatr Infect Dis Soc"},{"key":"B163","doi-asserted-by":"publisher","first-page":"103841","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: From bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMed"},{"key":"B164","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40794-017-0047-z","article-title":"The salivary gland as a target for enhancing immunization response","volume":"3","author":"Ponzio","year":"2017","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.03.055","article-title":"Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial","volume":"40","author":"Ortiz","year":"2022","journal-title":"Vaccine"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30240-2","article-title":"Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A\/17\/Turkey\/Turkey\/05\/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial","volume":"17","author":"Pitisuttithum","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1010859","article-title":"H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers","volume":"11","author":"Isakova-Sivak","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30584-5","article-title":"Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study","volume":"20","author":"Liebowitz","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat Med"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.crimmu.2022.10.001","article-title":"Mucosal delivery of RNA vaccines by Newcastle disease virus vectors","volume":"3","author":"Garc\u00eda-Sastre","year":"2022","journal-title":"Curr Res Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1649532","article-title":"Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens","volume":"15","author":"Fathi","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"B172","doi-asserted-by":"publisher","first-page":"100432","DOI":"10.1016\/j.dmpk.2021.100432","article-title":"Adenovirus vector-based vaccine for infectious diseases","volume":"42","author":"Sakurai","year":"2022","journal-title":"Drug Metab Pharmacokinet"},{"key":"B173","doi-asserted-by":"publisher","first-page":"103132","DOI":"10.1016\/j.ebiom.2020.103132","article-title":"Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate","volume":"62","author":"Sun","year":"2020","journal-title":"EBioMed"},{"key":"B174","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41541-022-00503-y","article-title":"The use of viral vectors in vaccine development","volume":"7","author":"Travieso","year":"2022","journal-title":"NPJ Vaccines"},{"key":"B175","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41541-021-00400-w","article-title":"Virus-based vaccine vectors with distinct replication mechanisms differentially infect and activate dendritic cells","volume":"6","author":"Chiale","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B176","doi-asserted-by":"publisher","first-page":"104203","DOI":"10.1016\/j.ebiom.2022.104203","article-title":"Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera","volume":"82","author":"Espeseth","year":"2022","journal-title":"EBioMed"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13352","article-title":"Formulation technologies for oral vaccines","volume":"198","author":"New","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01760","article-title":"AS03- and MF59-adjuvanted influenza vaccines in children","volume":"8","author":"Wilkins","year":"2017","journal-title":"Front Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2014.1004033","article-title":"CpG oligodeoxynucleotides as mucosal adjuvants","volume":"11","author":"Iho","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.5.2910-2919.2005","article-title":"Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection","volume":"79","author":"Ichinohe","year":"2005","journal-title":"J Virol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.08.086","article-title":"Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually","volume":"33","author":"Spinner","year":"2015","journal-title":"Vaccine"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21694","article-title":"Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine","volume":"82","author":"Ainai","year":"2010","journal-title":"J Med Virol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.07.058","article-title":"Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine","volume":"28","author":"Skountzou","year":"2010","journal-title":"Vaccine"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00110-4","article-title":"Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses","volume":"19","author":"Sj\u00f6lander","year":"2001","journal-title":"Vaccine"},{"key":"B186","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.vaccine.2004.12.006","article-title":"Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level","volume":"23","author":"Bracci","year":"2005","journal-title":"Vaccine"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00055-4","article-title":"Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin)","volume":"18","author":"Matsuo","year":"2000","journal-title":"Vaccine"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0138-2","article-title":"Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner","volume":"3","author":"Gopinath","year":"2018","journal-title":"Nat Microbiol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01598-21","article-title":"Oral bacteria combined with an intranasal vaccine protect from influenza A virus and SARS-CoV-2 infection","volume":"12","author":"Nagai","year":"2021","journal-title":"MBio"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c06350","article-title":"Artificial cell membrane polymersome-based intranasal beta spike formulation as a second generation Covid-19 vaccine","volume":"16","author":"Lam","year":"2022","journal-title":"ACS Nano"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-00835-2","article-title":"Therapeutically administered ribonucleoside analogue MK-4482\/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets","volume":"6","author":"Cox","year":"2021","journal-title":"Nat Microbiol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl7430","article-title":"A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus","volume":"14","author":"Fischer","year":"2022","journal-title":"Sci Transl Med"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.980002","article-title":"The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial","volume":"9","author":"Zhong","year":"2022","journal-title":"Front Med"},{"key":"B194","volume-title":"Influenza antiviral medications: Summary for clinicians","year":"2022"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008752","article-title":"Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action","volume":"17","author":"Czuppon","year":"2021","journal-title":"PloS Comput Biol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab247","article-title":"\u03b2-d-N4-hydroxycytidine inhibits SARS-CoV-2 through lethal mutagenesis but is also mutagenic to mammalian cells","volume":"224","author":"Zhou","year":"2021","journal-title":"J Infect Dis"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101049","article-title":"Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection","volume":"4","author":"Kim","year":"2021","journal-title":"Life Sci Alliance"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.3390\/v13030425","article-title":"The combination of bromelain and acetylcysteine (BromAc) synergistically inactivates SARS-CoV-2","volume":"13","author":"Akhter","year":"2021","journal-title":"Viruses"},{"key":"B199","doi-asserted-by":"crossref","first-page":"229 p","DOI":"10.1007\/978-3-319-28570-2","volume-title":"Utility of Bromelain and N-Acetylcysteine in Treatment of Peritoneal Dissemination of Gastrointestinal Mucin-Producing Malignancies","author":"Amini","year":"2016"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1007\/BF01150478","article-title":"Semliki Forest virus core protein fragmentation: its possible role in nucleocapsid disassembly","volume":"13","author":"Schlegel","year":"1993","journal-title":"Biosci Rep"},{"key":"B201","article-title":"Binding effects of concanavalin A on a coronavirus","volume":"41","author":"Greig","year":"1977","journal-title":"Can J Comp Med"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2076902","article-title":"Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review","volume":"54","author":"Lim","year":"2022","journal-title":"Ann Med"},{"key":"B203","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40463-020-00474-x","article-title":"Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework","volume":"49","author":"Naqvi","year":"2020","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12707","article-title":"Practical use of povidone-iodine antiseptic in the maintenance of oral health and in the prevention and treatment of common oropharyngeal infections","volume":"69","author":"Kanagalingam","year":"2015","journal-title":"Int J Clin Pract"},{"key":"B205","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jhin.2021.04.004","article-title":"Oral antiseptics against coronavirus: in-vitro and clinical evidence","volume":"113","author":"Mateos-Moreno","year":"2021","journal-title":"J Hosp Infect"},{"key":"B206","doi-asserted-by":"crossref","first-page":"439 p","DOI":"10.1007\/978-3-031-18903-6","volume-title":"Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2: A Multidisciplinary Perspective","author":"Mueller","year":"2023"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo2523","article-title":"Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses","volume":"378","author":"Mao","year":"2022","journal-title":"Science"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168037","article-title":"Combined oral and intravenous immunization stimulates strong igA responses in both systemic and mucosal compartments","volume":"11","author":"Yang","year":"2016","journal-title":"PloS One"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2006.0098","article-title":"Oral attenuated Salmonella enterica serovar Typhimurium vaccine expressing codon-optimized HIV type 1 Gag enhanced intestinal immunity in mice","volume":"23","author":"Tsunetsugu-Yokota","year":"2007","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1220610\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T05:00:48Z","timestamp":1697691648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1220610\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":209,"alternative-id":["10.3389\/fimmu.2023.1220610"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1220610","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"article-number":"1220610"}}